Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1180 | Obesity | ICEECE2012

Metabolic syndrome after liver transplantation: pre- and post-operative risk factors

Lunati M. , Grancini V. , Agnelli F. , Masserini B. , Zimbalatti D. , Rossi G. , Beck-Peccoz P. , Orsi E.

Background: Metabolic syndrome (MS) is a common condition among liver transplanted patients and it contributes to late morbidity and mortality by favoring the development of cardiovascular disease (CVD).The aim of this study was to assess the prevalence of MS in the first 6 months after orthotopic liver transplantation (OLT) and the associated pre-operative and post-operative risk factors.Methods: Seventy-one cirrhotic patients wer...

ea0029p1792 | Thyroid cancer | ICEECE2012

Circulating BRAFV600E in the diagnosis and follow up of differentiated thyroid cancer

Pupilli C. , Pinzani P. , Salvianti F. , Fibbi B. , Rossi M. , Petrone L. , De Feo M. , Forti G.

Introduction: Although overall accuracy of fine needle aspiration (FNA) in identifying thyroid cancer is considered excellent, 20–30% of aspirates do not allow definitive diagnosis of malignancy. Proto-oncogene somatic mutations such as BRAFV600E in FNA strongly suggest the presence of malignancy. However, only few studies reported the use of circulating BRAFV600E-mutated alleles in plasma as an useful marker for non invasive diagnosis and follow up of this disease.<p...

ea0026p141 | Male reproduction | ECE2011

Erectile dysfunction does not mirror endothelial dysfunction in hiv-infected patients

Santi D , Beggi M , Brigante G , Zona S , Luzi K , Orlando G , Rossi R , Bouloux P , Guaraldi G , Rochira V

Background: The penis has been compared to a barometer of endothelial health, being erectile dysfunction (ED) an early sign of endothelial dysfunction. The aim of the study was to investigate the association between ED and endothelial dysfunction in patients with HIV infection on ART.Methods: In this observational cross-sectional study we evaluated the prevalence and factors associated with ED in a cohort of 133 HIV-infected men. Evaluation tools include...

ea0022oc2.3 | Thyroid | ECE2010

Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies

Buratto Mattia , Tagliati Federico , Trasforini Giorgio , Leoni Stefania , Rossi Roberta , degli Uberti Ettore C , Zatelli Maria Chiara

Many studies demonstrated that somatic BRAF gene mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma (PTC), even from very small samples. The gold standard for point mutations research is direct sequencing, that implies DNA extraction, PCR with specific primers, sequencing reaction and run on an automatic sequencer. This is an expensive and time consuming method, and the possible contamination with wild-type DNA not coming from the nodule significan...

ea0022p451 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Prokineticin 1 stimulates prostate epithelial cell migration and proliferation in vitro

Visonti Daniela , Bellastella Giuseppe , Rossi Valentina , Chieffi Paolo , Maione Luigi , Punzo Paola , Bellastella Antonio , Sinisi Antonio Agostino

Prokineticin 1 (Prok1), the product of EGVEGF/PROK 1 gene, acts through two G-coupled receptors (PKR1 and PKR2) and is involved in a wide spectrum of actions, including tumorigenesis. Increased Prok1 expression has been found in prostate hyperplasia and cancer, suggesting a role in prostate cancer and BPH. Aim of this study was to elucidate the role of Prok1 on prostate cell function and growth. We evaluated the effects of Prok1 on epithelial prostate cell (PC) migration and p...

ea0022p661 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

SSTR5 ligand binding domain immunohistological detection in pituitary adenomas using Y-SSTR5 a new mouse monoclonal antibody

Rossi Valentina , Staibano Stefania , Del Basso De Caro Laura , Bellastella Giuseppe , Ilardi Gennaro , Cavallo Luigi , Colao Annamaria , Agostino Sinisi Antonio

Polyclonal antibodies against somatostatin receptors (SSTRs) available up to now recognizing intracellular sites of receptors and their recycling products do not detect bioactive ligand binding domains (LBDs) and are of limited performance in paraffin-embedded tissues. Aim of this study was to evaluate by immunohistochemistry the expression of SSTR5 on an archival series of pituitary tumors using a new MoAbs against the SST-binding domain (Y-SSTR5).Metho...

ea0020p206 | Endocrine tumours and neoplasia | ECE2009

Percutaneous laser ablation for palliative treatment of neuroendocrine liver metastases

Nasoni Silvia , Pacella Claudio Maria , Bianchini Antonio , Bizzarri Giancarlo , Rossi Zaccaria , Papini Enrico , Misischi Irene , Grimaldi Franco

Background: Liver metastases occur in about 40–85% of patients with neuroendocrine tumours (NET). NET usually run a rather indolent course but the 5-year survival is about 40% in patients with liver metastases versus 75–99% in subjects free of hepatic lesions. The most effective management and timing of treatment for patients with surgically unresectable metastases remains still unsettled.Purpose: To evaluate the feasibility, safety, and clinic...

ea0016oc2.5 | Thyroid | ECE2008

Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair

Cirello Valentina , Recalcati Maria Paola , Muzza Marina , Rossi Stefania , Perrino Michela , Beck-Peccoz Paolo , Finelli Palma , Fugazzola Laura

Fetal cells enter the maternal circulation during pregnancy and can persist in the maternal blood or tissues for decades, creating a physiological microchimerism. Since papillary thyroid cancer (PTC) is more frequent in female gender and it is the second more frequent tumor during pregnancy, the role of persisting microchimeric cells has been investigated. Tumour tissue specimens were obtained from 62 women with PTC, 41 of whom had at least one male child before the diagnosis ...

ea0014p571 | (1) | ECE2007

Riluzole treatment does not affect growth hormone (GH) secretion in amyotrophic lateral sclerosis

Morselli Lisa Linda , Bongioanni Paolo , Genovesi Maura , Licitra Rosaria , Rossi Bruno , Murri Luigi , Gasperi Maurizio , Martino Enio

Amyotrophic lateral sclerosis (ALS), the most common motor neurone disorder in human adults, presents is characterized by selective and progressive degeneration of upper and lower motor neurones in central nervous system. GH secretion, evaluated by GHRH+arginine test, has been recently reported to be impaired in about 70% of untreated ALS patients. The currently available drug for ALS treatment is riluzole, a compound acting through inhibition of glutamate relase, post-synapti...

ea0011p918 | Thyroid | ECE2006

Treatment of patients with Graves’ disease and ophthalmopathy with the anti-CD20 monoclonal antibody rituximab

Salvi M , Vannucchi GM , Campi I , Guastella C , Sbrozzi F , Simonetta S , Rossi S , Bonara P , Avignone S , Ratiglia R

We are conducting an open study on the treatment of Graves’ disease (GD) and thyroid-associated ophthalmopathy (TAO) with the monoclonal antibody to CD-20, rituximab (RTX) (MabThera, Hoffman-Roche, Basel). RTX induces depletion of B cells and GD is typically a B cell dependent autoimmune disease. We present preliminary results on 7 patients with GD and TAO at different clinical stages: 3 women with newly diagnosed GD and initial TAO; 1 woman with GD and moderate-severe TA...